MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial

Objectives To investigate changes in the Apparent Diffusion Coefficient (ADC) using diffusion-weighted imaging (DWI) in men on active surveillance for prostate cancer taking dutasteride 0.5 mg or placebo . Methods We analysed 37 men, randomised to 6 months of daily dutasteride (n = 18) or placebo (n...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European radiology 2017-11, Vol.27 (11), p.4767-4774
Hauptverfasser:	Giganti, Francesco, Moore, Caroline M., Robertson, Nicola L., McCartan, Neil, Jameson, Charles, Bott, Simon R. J., Winkler, Mathias, Gambarota, Giulio, Whitcher, Brandon, Castro, Ramiro, Emberton, Mark, Allen, Clare, Kirkham, Alex
Format:	Artikel
Sprache:	eng
Schlagworte:	5-alpha Reductase Inhibitors - therapeutic use Aged Bioengineering Biopsy Cancer Clinical trials Conspicuity Diagnostic Radiology Diffusion coefficient Diffusion Magnetic Resonance Imaging Dutasteride - therapeutic use Human health and pathology Humans Imaging Internal Medicine Interventional Radiology Lesions Life Sciences Magnetic resonance imaging Male Medication Medicine Medicine & Public Health Men Middle Aged Neuroradiology NMR Nuclear magnetic resonance Pharmaceutical sciences Prostate cancer Prostatic Hyperplasia - drug therapy Prostatic Neoplasms - diagnostic imaging Prostatic Neoplasms - pathology Radiology Randomization Reviews Surveillance Tumors Ultrasound Urogenital Urology and Nephrology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!